Executive Order On Psychedelic Drugs in the US - a milestone(d)

[ElectricEgregore]

Think of this administration what you like, at least we can now observe the odd presentation
of Joe Rogan standing in the Oval Office celebrating the executive order on psychedelic drugs signed just now.

Please, Log in or Register to view URLs content!

What it means?

Here a little AI summary of what was signed today:

The following key points were decided in the original text:

FDA Acceleration: The FDA is directed to grant "Commissioner’s National Priority Vouchers" to psychedelic drugs that have already received Breakthrough Therapy designation (e.g., substances like psilocybin or ibogaine). This prioritizes and accelerates the regulatory review process for approval.

Access via Right-to-Try Act: The FDA and DEA must establish a pathway enabling eligible patients—those who have exhausted all standard treatments—to access unapproved psychedelic substances currently under FDA review (explicitly including ibogaine compounds) under the Right-to-Try Act. This includes providing necessary exemptions for Schedule I substances, the most strictly controlled category.

$50 Million in Funding: The Department of Health and Human Services (HHS) must allocate at least $50 million through the ARPA-H program. These funds are intended to match investments by state governments that are developing or have established psychedelic research or therapy programs.

Collaboration with Veterans Affairs and Private Sector: HHS, the FDA, and the Department of Veterans Affairs (VA) are required to strengthen cooperation—including data sharing—with each other and, where appropriate, with the private sector. The goal is to accelerate clinical trials and gather more real-world evidence on psychedelic treatments.

Faster Rescheduling: The Attorney General, in consultation with HHS, must initiate and complete the review process for any product containing a Schedule I substance once it has successfully completed Phase 3 clinical trials and received FDA approval. This could lead to a reclassification (descheduling), but only for approved medical products.

Summary: The executive order opens pathways for faster research and very limited therapeutic access—primarily through the Right-to-Try framework for critically ill patients—provides funding support for state-level initiatives, and prepares the regulatory groundwork for future approvals. Psychedelic substances remain classified as Schedule I and illegal outside these strictly regulated medical contexts.

The full executive order and fact sheet are available on whitehouse.gov (dated April 18, 2026).

As I'm interested in this topic for a long time, meaning psychedelics, steps towards legalization and the deelopment of psychedelic therapies to give truly healthy options for all kinds of mental issues, even to ease pain and facilitate acceptance in more serious cases - this is truly a milestone towards a more humane way of organizing medicine.

Even if many things stay in the realms of the 'Big Yap' - the funding for research for good people is real, the push of the overton window is real.

This may give the right tools to the right people in the right moment - and even if it's halted or forbidden later again -
the Djinn isout of the bottle, new things will be found and developed!

I thought I'll share these news with you, looking foreward to your thoughts on this!

 

[Sedim Haba]

Anything on Cannabis in there?